124 related articles for article (PubMed ID: 18567424)
1. [Persistent trophoblastic disease in Trophoblastic Disease Center in the Czech Republic in 1955--2007].
Zavadil M; Feyereisl J; Krofta L; Safár P; Turyna R
Ceska Gynekol; 2008 Apr; 73(2):73-9. PubMed ID: 18567424
[TBL] [Abstract][Full Text] [Related]
2. [Malignant trophoblastic tumors (MTT) treated in the years 1955-2004 in trophoblastic disease center in the Czech Republic (TDC-CZ): clinical-pathological features, curability, typing, pathogenesis].
Zavadil M; Feyereisl J; Safár P; Pán M
Ceska Gynekol; 2004 Dec; 69 Suppl 1():9-15. PubMed ID: 15748020
[TBL] [Abstract][Full Text] [Related]
3. [Syndrome of persistent low levels of human chorionic gonadotrophin (hCG)].
Zavadil M; Feyereisl J; Safár P; Pán M; Turyna R
Ceska Gynekol; 2006 Mar; 71(2):136-42. PubMed ID: 16649415
[TBL] [Abstract][Full Text] [Related]
4. [Undifferentiated choriocarcinoma--epithelioid trophoblastic tumors treated at the Center for Trophoblastic Diseases in the Czech Republic 1955-2003].
Zavadil M; Feyereisl J; Safár P; Pán M
Ceska Gynekol; 2003 Nov; 68(6):420-6. PubMed ID: 15042852
[TBL] [Abstract][Full Text] [Related]
5. [Quiscent trophoblastic disease].
Hron F; Hejda V; Feyereisl J; Safár P; Sochová H
Ceska Gynekol; 2011 Dec; 76(6):443-6. PubMed ID: 22312838
[TBL] [Abstract][Full Text] [Related]
6. [Results of gestational trophoblastic neoplasia treatment in the Slovak Republic in the years from 1993 to 2012].
Korbeľ M; Šufliarsky J; Danihel Ľ; Vojtaššák J; Nižňanská Z
Ceska Gynekol; 2016 Jan; 81(1):6-13. PubMed ID: 26982057
[TBL] [Abstract][Full Text] [Related]
7. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
8. [Complete molar pregancy with development of non-metastatic persistent trophoblastic diseaseA case report, reflection of rules of care and decision-making processes Forensic responsibility and the position of doctor in the general gynecologic and obstetric outpatient practice].
Zeman S; Trávník P; Dvořáková K; Zemanová J
Ceska Gynekol; 2017; 82(5):396-406. PubMed ID: 29020788
[TBL] [Abstract][Full Text] [Related]
9. [New diagnostic approach to different hydatidiform mole types, hydropic abortions and relevant clinical management].
Zavadil M; Feyereisl J; Krofta L; Safár P; Kucerová I
Ceska Gynekol; 2009 Jun; 74(3):177-82. PubMed ID: 19642515
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
11. [Histological differential diagnosis of hydatidiform moles and hydropic abortions].
Zavadil M; Feyereisl J; Hejda V; Krofta L; Safár P
Cesk Patol; 2009 Jan; 45(1):3-8. PubMed ID: 19402314
[TBL] [Abstract][Full Text] [Related]
12. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
14. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
15. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
17. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.
Maestá I; Growdon WB; Goldstein DP; Bernstein MR; Horowitz NS; Rudge MV; Berkowitz RS
Gynecol Oncol; 2013 Aug; 130(2):312-6. PubMed ID: 23707672
[TBL] [Abstract][Full Text] [Related]
19. [DNA analysis in gestational trophoblastic disease].
Repiská V; Vojtassák J; Korbel' M; Danihel L; Sufliarsky J; Niznanská Z; Redecha M; Ilavská I
Ceska Gynekol; 2003 Nov; 68(6):442-8. PubMed ID: 15042856
[TBL] [Abstract][Full Text] [Related]
20. [Gestational trophoblastic disease].
Allias F; Bolze PA; Gaillot-Durand L; Devouassoux-Shisheboran M;
Ann Pathol; 2014 Dec; 34(6):434-47. PubMed ID: 25499859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
